| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Center for Human Genetics,* University of Bremen, Bremen; the Tumor Biology Center, Institute of Molecular Medicine, Freiburg; and the Department of Gynecopathology, Institute of Pathology, University Hospital Eppendorf, Hamburg, Germany
The initiation of angiogenesis, called the angiogenetic switch, is a crucial early step in tumor progression and propagation, ensuring an adequate oxygen supply. The rapid growth of tumors is accompanied by a reduced microvessel density, resulting in chronic hypoxia that often leads to necrotic areas within the tumor. These hypoxic and necrotic regions exhibit increased expression of angiogenetic growth factors, eg, vascular endothelial growth factor, and may also attract macrophages, which are known to produce a number of potent angiogenetic cytokines and growth factors. A group of molecules that may act as mediators of angiogenesis are the so-called high-mobility group proteins. Recent studies showed that HMGB1, known as an architectural chromatin-binding protein, can be extracellularly released by passive diffusion from necrotic cells and activated macrophages. To examine the angiogenetic effects of HMGB1 on endothelial cells an in vitro spheroid model was used. The results of the endothelial-sprouting assay clearly show that exogenous HMGB1 induced endothelial cell migration and sprouting in vitro in a dose-dependent manner. Thus, this is the first report showing strong evidence for HMGB1-induced sprouting of endothelial cells.
This article has been cited by other articles:
 |
|
 |
|
  N. Hamada, T. Maeyama, T. Kawaguchi, M. Yoshimi, J. Fukumoto, M. Yamada, S. Yamada, K. Kuwano, and Y. Nakanishi The Role of High Mobility Group Box1 in Pulmonary Fibrosis Am. J. Respir. Cell Mol. Biol., October 1, 2008; 39(4): 440 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Takahashi High-mobility group box 1 protein (HMGB1) in ischaemic heart disease: beneficial or deleterious? Cardiovasc Res, October 1, 2008; 80(1): 5 - 6. [Full Text] [PDF]
|
|
|
|
|
|
T. Kitahara, Y. Takeishi, M. Harada, T. Niizeki, S. Suzuki, T. Sasaki, M. Ishino, O. Bilim, O. Nakajima, and I. Kubota High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice Cardiovasc Res, October 1, 2008; 80(1): 40 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Coffelt and A. B. Scandurro Tumors Sound the Alarmin(s) Cancer Res., August 15, 2008; 68(16): 6482 - 6485. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-P. Tzeng, J. Fan, J. G. Vallejo, J. W. Dong, X. Chen, S. R. Houser, and D. L. Mann Negative inotropic effects of high-mobility group box 1 protein in isolated contracting cardiac myocytes Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1490 - H1496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. De Mori, S. Straino, A. Di Carlo, A. Mangoni, G. Pompilio, R. Palumbo, M. E. Bianchi, M. C. Capogrossi, and A. Germani Multiple Effects of High Mobility Group Box Protein 1 in Skeletal Muscle Regeneration Arterioscler. Thromb. Vasc. Biol., November 1, 2007; 27(11): 2377 - 2383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Taniguchi, K. Yoshida, T. Ito, M. Tsuda, Y. Mishima, T. Furumatsu, L. Ronfani, K. Abeyama, K.-i. Kawahara, S. Komiya, et al. Stage-Specific Secretion of HMGB1 in Cartilage Regulates Endochondral Ossification Mol. Cell. Biol., August 15, 2007; 27(16): 5650 - 5663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Fernandez-Lopez, E. M. Garrido-Martin, F. Sanz-Rodriguez, M. Pericacho, A. Rodriguez-Barbero, N. Eleno, J. M. Lopez-Novoa, A. Duwell, M. A. Vega, C. Bernabeu, et al. Gene expression fingerprinting for human hereditary hemorrhagic telangiectasia Hum. Mol. Genet., July 1, 2007; 16(13): 1515 - 1533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ponsuksili, E. Murani, C. Walz, M. Schwerin, and K. Wimmers Pre- and postnatal hepatic gene expression profiles of two pig breeds differing in body composition: insight into pathways of metabolic regulation Physiol Genomics, May 11, 2007; 29(3): 267 - 279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Chavakis, A. Hain, M. Vinci, G. Carmona, M. E. Bianchi, P. Vajkoczy, A. M. Zeiher, T. Chavakis, and S. Dimmeler High-Mobility Group Box 1 Activates Integrin-Dependent Homing of Endothelial Progenitor Cells Circ. Res., February 2, 2007; 100(2): 204 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Germani, F. Limana, and M. C. Capogrossi Pivotal Advances: High-mobility group box 1 protein--a cytokine with a role in cardiac repair J. Leukoc. Biol., January 1, 2007; 81(1): 41 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Popovic, R. DeMarco, M. T. Lotze, S. E. Winikoff, D. L. Bartlett, A. M. Krieg, Z. S. Guo, C. K. Brown, K. J. Tracey, and H. J. Zeh III High Mobility Group B1 Protein Suppresses the Human Plasmacytoid Dendritic Cell Response to TLR9 Agonists J. Immunol., December 15, 2006; 177(12): 8701 - 8707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. van Beijnum, R. P. Dings, E. van der Linden, B. M. M. Zwaans, F. C. S. Ramaekers, K. H. Mayo, and A. W. Griffioen Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature Blood, October 1, 2006; 108(7): 2339 - 2348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mitola, M. Belleri, C. Urbinati, D. Coltrini, B. Sparatore, M. Pedrazzi, E. Melloni, and M. Presta Cutting Edge: Extracellular High Mobility Group Box-1 Protein Is a Proangiogenic Cytokine J. Immunol., January 1, 2006; 176(1): 12 - 15. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
